Parmax Pharma bulk deals, insider trading and stake changes
BSE: 540359Pharmaceuticals & BiotechnologySmall Cap
Last close ₹136.40down ₹1.35 (0.98%)
Share price at the BSE close on 19 Oct 2026. Previous close ₹137.75.
52-week range of traded prices to 19 Oct 2026
₹22.60Low, 25 Mar 2026₹139.10High, 5 Oct 2026
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹94 Cr4,411th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business.
- Net worth zero or below
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −70.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- Net worth zero or below
- Volume, BSEVolume. Shares traded on the last trading day.
- 271
Promoter and insider buying and selling
Trades made since 23 Oct 2025.Parmax Pharma promoter holding
No promoter, director, key manager or employee bought or sold on the market.
- Promoters and promoter group: no market trade · 14 off-market moves
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Parmax Pharma insider trading
All 21 disclosures on record.Insider trading, all companies
Aug 2026
- DHAIRYA DHIREN SHAH₹0.44 Cr1,20,838 sharesReceived · Promoter Group · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 93,448 before, holds 2,14,286 after
- RUPA SUNIL SHAH₹0.25 Cr69,206 sharesReceived · Promoter Group · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 53,520 before, holds 1,22,726 after
- NIRMAL SUNILBHAI SHAH₹0.60 Cr1,64,832 sharesReceived · Promoter Group · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 1,24,597 before, holds 2,89,429 after
- ABHAY CHINUBHAI SHAH₹1.18 Cr3,22,235 sharesReceived · Promoter Group · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 2,49,394 before, holds 5,71,629 after
- KAMLESH NATVARLAL SHIYANI₹0.59 Cr1,61,974 sharesReceived · Promoter Group · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 1,24,597 before, holds 2,86,571 after
- VIJAYKUMAR NATVARLAL SHIYANI₹0.59 Cr1,61,117 sharesReceived · Promoter Group · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 1,24,597 before, holds 2,85,714 after
- SHEETAL HIREN DOSHI₹0.09 Cr24,167 sharesReceived · Promoter Group · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 18,690 before, holds 42,857 after
- UMANG ALKESH GOSALIA₹1.25 Cr3,42,466 sharesReceived · Promoter and Director · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 2,00,000 before, holds 5,42,466 after
- HIREN PRAVIN DOSHI₹0.79 Cr2,17,508 sharesReceived · Promoter · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 1,68,206 before, holds 3,85,714 after
- SUNIL CHINUBHAI SHAH₹0.34 Cr91,911 sharesReceived · Promoter and Director · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 71,077 before, holds 1,62,988 after
- DHIREN CHANDULAL SHAH₹2.21 Cr6,04,190 sharesReceived · Promoter and Director · 29 Aug 2026 · disclosed 1 Sep · Preferential Offer · held 4,67,238 before, holds 10,71,428 after
- PRAVINA M GOPANI₹24,500700 sharesGave · Promoter Group · 13 Aug 2026 · disclosed 18 Aug · Off Market · held 700 before, holds none after
- VIPUL M GOPANI₹1.68 Cr4,81,370 sharesGave · Promoter · 13 Aug 2026 · disclosed 18 Aug · Off Market · held 4,81,370 before, holds none after
- ALKESH M GOPANI₹2.35 Cr6,70,380 sharesGave · Promoter · 13 Aug 2026 · disclosed 18 Aug · Off Market · held 6,70,380 before, holds none after
Apr 2022
- GOSALIA MEENA ALKESH2,54,800sharesReceived · Directors Immediate Relative · 8 Apr 2022 · disclosed 19 Apr · Inter-se-Transfer · stake 4.54% before, 11.35% after
Dec 2021
- VIPUL MAHASUKH GOPANI3,81,170sharesReceived · Promoter · 1 Dec 2021 · disclosed 3 Dec · Gift · stake 2.67% before, 12.86% after
- PRAVINA MAHASUKHLAL GOPANI3,81,170sharesGave · Promoter Immediate Relative · 1 Dec 2021 · disclosed 4 Dec · Gift · held 3,81,170 before, holds none after
Sep 2021
- PRAVINA MAHASUKHLAL GOPANI3,81,170sharesGave · Promoter Group · 30 Sep 2021 · disclosed 7 Oct · Gift · stake 20.38% before, 10.19% after
- ALKESH M. GOPANI3,81,170sharesReceived · Promoter · 30 Sep 2021 · disclosed 7 Oct · Gift · stake 7.73% before, 17.92% after
Dec 2020
- Pravina Mahasukhlal Gopani7,48,260sharesReceived · Promoter Group · 18 Dec 2020 · disclosed 23 Dec · Inheritance · stake 0.38% before, 20.38% after
Apr 2017
- Vipul Mahasukh Gopani61,700sharesReceived · Promoter & Director · 14 Apr 2017 · disclosed 13 Jul · Market · held 38,500 before, holds 1,00,200 after, stake 2.68% after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Parmax Pharma stake sales and purchases
All 12 disclosures on record.
Dec 2021
- AcquiredVipul M Gopani10.19% of the company3,81,170 shares1 Dec 2021 · filed as exempt from an open offer
- AcquiredVipul M Gopani · promoter10.19% of the company3,81,170 sharesholds 12.86% after1 Dec 2021 · filed under the 2% rule · Off Market / Inter se transfer
- SoldPravina Mahasukhlal Gopani · promoter10.19% of the company3,81,170 shares1 Dec 2021 · filed under the 2% rule · Off Market / Inter se transfer
- ProposedVipul Mahasukh Gopani · promoter10.19% of the company3,81,170 shares1 Dec 2021 · notice before a transfer exempt from an open offer
Sep 2021
- AcquiredAlkesh M Gopani10.19% of the company3,81,170 shares30 Sep 2021 · filed as exempt from an open offer
- SoldPravina Mahasukhlal Gopani · promoter10.19% of the company3,81,170 sharesholds 10.19% after30 Sep 2021 · filed under the 2% rule · Off Market Gift
- AcquiredAlkesh M Gopani · promoter10.19% of the company3,81,170 sharesholds 17.92% after30 Sep 2021 · filed under the 2% rule · Off Market Gift
Dec 2020
- AcquiredPravina Mahasukhlal Gopani20.38% of the company7,62,340 shares24 Dec 2020 · filed as exempt from an open offer
- AcquiredPravina Mahasukhlal Gopani · promoter20.00% of the company7,48,260 sharesholds 20.38% after18 Dec 2020 · filed under the 2% rule · Market
Oct 2018
- AcquiredPravina Mahasukhlal Gopani · promoter0.38% of the company14,080 sharesholds 0.38% after12 Oct 2018 · filed under the 2% rule · Will
- AcquiredPravina Mahasukhlal Gopani0.38% of the company14,080 shares12 Oct 2018 · filed as exempt from an open offer
Jun 2017
- AcquiredVipul Mahasukh Gopani · promoter1.03% of the company38,500 sharesholds 2.68% after23 Jun 2017 · filed under the 2% rule · Market
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.
Parmax Pharma bulk deals
Last 12 months, since 23 Oct 2025: 15 bulk deals, ₹2.83 Cr bought and ₹2.88 Cr sold Bought and sold in deals. Each deal's shares times its price, added up for the buyers and apart for the sellers, so a block deal, which names both, counts on each side.Today's bulk and block deals, all companies
ValueValue of a deal. The shares traded times the deal's price.Per cent of the companyPer cent of the company. The shares traded as a percentage of all the company's shares in issue on the day of the deal.
Monday 24 Aug 20261 firm · ₹0.26 Cr bought · ₹0 soldNet bought ₹0.26 Cr
- BoughtRAJESH JOSEPHBought 20,000 at ₹131.150.53% of the company₹0.26 Cr
Wednesday 5 Aug 20262 firms · ₹0.56 Cr bought · ₹0.30 Cr soldNet bought ₹0.26 Cr
- BoughtRAJESH JOSEPHBought 55,751 at ₹100.631.49% of the company₹0.56 Cr
- SoldNEO APEX SHARE BROKING SERVICES LLPSold 30,000 at ₹101.650.80% of the company₹0.30 Cr
Friday 31 Jul 20261 firm · ₹0 bought · ₹0.27 Cr soldNet sold ₹0.27 Cr
- SoldPARESH DHIRAJLAL SHAHSold 25,427 at ₹104.780.68% of the company₹0.27 Cr
Thursday 30 Jul 20263 firms · ₹0.67 Cr bought · ₹0.97 Cr soldNet sold ₹0.31 Cr
- SoldGUTTIKONDA VARA LAKSHMISold 87,547 at ₹111.002.34% of the company₹0.97 Cr
- BoughtNEO APEX SHARE BROKING SERVICES LLPBought 30,000 at ₹111.000.80% of the company₹0.33 Cr
- BoughtPARESH DHIRAJLAL SHAHBought 30,000 at ₹111.000.80% of the company₹0.33 Cr
Monday 27 Jul 20264 firms · ₹1.11 Cr bought · ₹0.81 Cr soldNet bought ₹0.31 Cr
- BoughtGUTTIKONDA VARA LAKSHMIBought 99,000 at ₹100.782.65% of the company₹1.00 Cr
- SoldNEO APEX SHARE BROKING SERVICES LLPSold 25,790 at ₹100.780.69% of the company₹0.26 Cr
- Both waysMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 10,897 at ₹104.88Sold 32,849 at ₹100.780.88% of the companyNet −21,952 shares₹0.11 Cr bought
- SoldEPITOME TRADING AND INVESTMENTSSold 21,312 at ₹100.780.57% of the company₹0.21 Cr
Monday 13 Jul 20262 firms · ₹0.23 Cr bought · ₹0.31 Cr soldNet sold ₹0.07 Cr
- SoldPARESH DHIRAJLAL SHAHSold 33,000 at ₹93.300.88% of the company₹0.31 Cr
- BoughtMULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITEDBought 25,000 at ₹93.300.67% of the company₹0.23 Cr
Tuesday 23 Jun 20261 firm · ₹0 bought · ₹0.22 Cr soldNet sold ₹0.22 Cr
- SoldBHARTI DEEPAK MEHTASold 30,742 at ₹72.170.82% of the company₹0.22 Cr
A bulk deal is one client trading half a per cent or more of the shares in a day; a block deal is a large trade in the exchange's separate block window, its buyer and its seller each on a line of their own. A firm that bought and sold the shares the same day is on one line, with its net. All 15 deals on record since listing on 16 Mar 2017.